$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

$tsoi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224021937 Filed on May 30, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$21.81K	$23.12K
YoY Change	-5.66%	-72.76%
Cost Of Revenue	$7.490K	$8.466K
YoY Change	-11.53%	-46.89%
Gross Profit	$14.32K	$14.66K
YoY Change	-2.27%	-78.75%
Gross Profit Margin	65.66%	63.39%
Selling, General & Admin	$629.0K	$391.8K
YoY Change	60.53%	34.41%
% of Gross Profit	4390.88%	2673.13%
Research & Development	$58.61K	$52.73K
YoY Change	11.16%	-82.66%
% of Gross Profit	409.19%	359.74%
Depreciation & Amortization	$2.720K	$2.720K
YoY Change	0.0%	-60.29%
% of Gross Profit	18.99%	18.56%
Operating Expenses	$687.6K	$444.5K
YoY Change	54.67%	-25.37%
Operating Profit	-$673.2K	-$429.9K
YoY Change	56.62%	-18.38%
Interest Expense	$89.19K	$121.8K
YoY Change	-26.78%	-264.1%
% of Operating Profit
Other Income/Expense, Net	-$91.03K	-$148.0K
YoY Change	-38.5%	99.42%
Pretax Income	-$764.3K	-$577.9K
YoY Change	32.25%	-3.83%
Income Tax
% Of Pretax Income
Net Earnings	-$585.1K	-$577.9K
YoY Change	1.26%	-3.83%
Net Earnings / Revenue	-2682.41%	-2499.16%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	3.954B shares	2.734B shares
Diluted Shares Outstanding	3.954B shares	2.692B shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.48K	$18.53K
YoY Change	188.61%	-88.82%
Cash & Equivalents	$53.48K	$18.53K
Short-Term Investments
Other Short-Term Assets	$2.628M	$128.5K
YoY Change	1944.88%	-81.64%
Inventory	$19.24K	$35.69K
Prepaid Expenses	$22.70K	$31.73K
Receivables	$18.16K	$17.73K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$924.3K	$200.5K
YoY Change	361.11%	-78.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$371.6K	$270.4K
YoY Change	37.46%	-13.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.632M	$2.935M
YoY Change	-10.32%	2900.18%
Total Long-Term Assets	$3.124M	$3.349M
YoY Change	-6.74%	-12.77%
TOTAL ASSETS
Total Short-Term Assets	$924.3K	$200.5K
Total Long-Term Assets	$3.124M	$3.349M
Total Assets	$4.048M	$3.550M
YoY Change	14.04%	-25.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$385.3K	$398.9K
YoY Change	-3.42%	7.11%
Accrued Expenses	$574.7K	$544.9K
YoY Change	5.47%	5.97%
Deferred Revenue
YoY Change
Short-Term Debt	$797.7K	$1.056M
YoY Change	-24.43%	-1.68%
Long-Term Debt Due	$4.640K	$4.640K
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$1.945M	$2.255M
YoY Change	-13.74%	-8.32%
LONG-TERM LIABILITIES
Long-Term Debt	$4.190K	$9.300K
YoY Change	-54.95%	-33.05%
Other Long-Term Liabilities	$92.98K	$120.1K
YoY Change	-22.59%	5486.51%
Total Long-Term Liabilities	$97.17K	$129.4K
YoY Change	-24.91%	706.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.945M	$2.255M
Total Long-Term Liabilities	$97.17K	$129.4K
Total Liabilities	$2.043M	$2.385M
YoY Change	-14.35%	-3.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.91M	-$18.25M
YoY Change	14.58%
Common Stock	$4.230M	$2.749M
YoY Change	53.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.409M	$1.165M
YoY Change
Total Liabilities & Shareholders Equity	$4.048M	$3.550M
YoY Change	14.04%	-25.75%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$585.1K	-$577.9K
YoY Change	1.26%	-3.83%
Depreciation, Depletion And Amortization	$2.720K	$2.720K
YoY Change	0.0%	-60.29%
Cash From Operating Activities	-$205.5K	-$201.1K
YoY Change	2.2%	-6.42%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.950K
YoY Change	-100.0%
Cash From Investing Activities		$1.951K
YoY Change		-100.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$149.1K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$231.2K	$199.6K
YoY Change	15.8%	-58.97%
NET CHANGE
Cash From Operating Activities	-$205.5K	-$201.1K
Cash From Investing Activities		$1.951K
Cash From Financing Activities	$231.2K	$199.6K
Net Change In Cash	$25.65K	$491.00
YoY Change	5124.85%	-99.31%
FREE CASH FLOW
Cash From Operating Activities	-$205.5K	-$201.1K
Capital Expenditures		$0.00
Free Cash Flow		-$201.1K
YoY Change		-6.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	231	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	TSOI	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	TSOI	Common Stock Issued For Prepaid Fees Value CommonStockIssuedForPrepaidFeesValue		usd
CY2024Q1	TSOI	Common Stock Issued For Accrued Salaries Value CommonStockIssuedForAccruedSalariesValue		usd
CY2024Q1	TSOI	Common Stock Issued For License Value CommonStockIssuedForLicenseValue		usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash		usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92981	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53477	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18160	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	19238	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	833425	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	924300	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	371635	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	120107	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2631993	usd
CY2024Q1	us-gaap	Assets Assets	4048035	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	574744	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	27126	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	85384	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	89616	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	155987	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	181070	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1945494	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	4185	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2042660	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4230116869	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4230116869	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3802666978	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3802666978	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4230118	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18111652	usd
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	21000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20911606	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1409165	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	596210	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2005375	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4048035	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21814	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7490	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8466	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	14324	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	14657	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110873	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	119401	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	110357	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	110525	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	260140	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	69284	usd
CY2024Q1	us-gaap	Legal Fees LegalFees	147583	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	92587	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58612	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52727	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	687565	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	444524	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-673241	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-429867	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-34241	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18134	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	32404	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-44336	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	89190	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	121812	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-91027	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-148014	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-764268	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-577881	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-764268	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-577881	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-179127	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-585141	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-577881	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3953546003	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3953546003	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2692056744	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2692056744	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1385181	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	19600	usd
CY2023Q1	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	20000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	130086	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	188459	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-577881	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1165445	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1281882	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1281882	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	45900	usd
CY2024Q1	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees	20000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	149091	usd
CY2024Q1	TSOI	Stock Issued During Period Value New Issues Preferred Stock StockIssuedDuringPeriodValueNewIssuesPreferredStock	10000	usd
CY2024Q1	TSOI	Adjustments To Additional Paid In Capital Subsidiary For Services AdjustmentsToAdditionalPaidInCapitalSubsidiaryForServices	1125000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	137770	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-764268	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2005375	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2005375	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-764268	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-577881	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1146600	usd
CY2024Q1	TSOI	Share Based Compensation To Related Parties ShareBasedCompensationToRelatedParties	24300	usd
CY2023Q1	TSOI	Share Based Compensation To Related Parties ShareBasedCompensationToRelatedParties	19600	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-34241	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18134	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	32404	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-44336	usd
CY2024Q1	TSOI	Amortization Of Prepaid Stock Based Compensation AmortizationOfPrepaidStockBasedCompensation	7319	usd
CY2023Q1	TSOI	Amortization Of Prepaid Stock Based Compensation AmortizationOfPrepaidStockBasedCompensation	60943	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	77000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	106664	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74194	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74194	usd
CY2024Q1	us-gaap	Depreciation Depreciation	2720	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2720	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1036	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7672	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3336	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6743	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	804424	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37605	usd
CY2024Q1	TSOI	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	5450	usd
CY2023Q1	TSOI	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	10630	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-22109	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-10283	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2496	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	8	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	44454	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	44735	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5450	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10630	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-205509	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-201078	usd
CY2023Q1	TSOI	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	-1951	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1951	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	8	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3401	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	70000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	70750	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1326	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1210	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	10000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	149091	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	130086	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	231163	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	199618	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25654	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	491	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27823	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29043	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53477	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29534	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	269	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	663	usd
CY2024Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	20000	usd
CY2023Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	8500	usd
CY2024Q1	TSOI	Debt Discount Recorded In Connection With Derivative Liability DebtDiscountRecordedInConnectionWithDerivativeLiability	30000	usd
CY2023Q1	TSOI	Debt Discount Recorded In Connection With Derivative Liability DebtDiscountRecordedInConnectionWithDerivativeLiability	69565	usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	137770	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	188459	usd
CY2024Q1	TSOI	Common Stock Issued For Prepaid Fees Value CommonStockIssuedForPrepaidFeesValue	20000	usd
CY2023Q1	TSOI	Common Stock Issued For Accrued Salaries Value CommonStockIssuedForAccruedSalariesValue	20000	usd
CY2024Q1	TSOI	Accrued Interest Added To Principal AccruedInterestAddedToPrincipal	1978	usd
CY2023Q1	TSOI	Accrued Interest Added To Principal AccruedInterestAddedToPrincipal	6479	usd
CY2023Q1	TSOI	Common Stock Issued For License Value CommonStockIssuedForLicenseValue	146244	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	146244	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53477	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18531	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	11003	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53477	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29534	usd
CY2024Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2007-08-06
CY2024Q1	TSOI	Losses For Period LossesForPeriod	-20800000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10647	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6807	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21814	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23123	usd
CY2024Q1	TSOI	Wholesale Purchase Price And Payments Description WholesalePurchasePriceAndPaymentsDescription	Seller agrees to sell the Goods to Buyer for Fifty Percent (50%) off Sellers listed retail price. Seller will provide an invoice to Buyer at the time of delivery. All invoices must be paid, in full, within thirty (30) days. Any balances not paid within thirty (30) days will be subject to a five percent (5%) late payment penalty. In the event Buyer exceeds the aggregate of $500,000 worth of aforementioned products having been purchased, delivered, and paid for, Buyer will be entitled to an additional Five Percent (5%) discount up to the aggregate of $750,000.00. In the event Buyer exceeds the aggregate of $750,000 worth of aforementioned products having been purchased, delivered, and paid for, Buyer will be entitled to an additional Five Percent (5%) discount up to the aggregate of $1,500,000.00. All future sales after initial $1,500,000 in aggregate purchases will be sold at 60% off retail.
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	155987	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	181070	usd
CY2023Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	181070	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	85264	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet	-77943	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	-32404	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	155987	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52727	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zBGHhAhhPBDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z0JqMBDrVTne">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates were made relating to valuation allowances, impairment of assets, share-based compensation expense and accruals. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1239961976	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	372997016	shares
CY2024Q1	us-gaap	Depreciation Depreciation	2720	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2720	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74194	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74194	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	685	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58612	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	120107	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	22697	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11037	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1028	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1167	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	809700	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4116	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	833425	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16320	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	413517	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	413517	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41882	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39162	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	371635	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	374355	usd
CY2024Q1	us-gaap	Depreciation Depreciation	2720	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2720	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2627870	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2702064	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	4123	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	4123	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2631993	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2706187	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3261122	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3261122	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	633252	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	559058	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2627870	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2702064	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74194	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74194	usd
CY2024Q1	us-gaap	Payments Of Derivative Issuance Costs PaymentsOfDerivativeIssuanceCosts	85264	usd
CY2024Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	5505000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4230116869	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1002	shares
CY2023	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	110000	usd
CY2023	TSOI	Stock Issued During Period Common Stock Issued For Land Development StockIssuedDuringPeriodCommonStockIssuedForLandDevelopment	96000	usd
CY2024Q1	TSOI	Preferred Stock Stated Percentage PreferredStockStatedPercentage	1	pure
CY2024Q1	TSOI	Debt Instrument Threshold Trading Days DebtInstrumentThresholdTradingDays	P20D
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1700	sqft
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P60M
CY2023Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2028-04-30
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	6384	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	6261	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.011	pure

Files In Submission

Name	View Source	Status
0001493152-24-021937-index-headers.html	Edgar Link	pending
0001493152-24-021937-index.html	Edgar Link	pending
0001493152-24-021937.txt	Edgar Link	pending
0001493152-24-021937-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
tsoi-20240331.xsd	Edgar Link	pending
tsoi-20240331_def.xml	Edgar Link	unprocessable
tsoi-20240331_pre.xml	Edgar Link	unprocessable
tsoi-20240331_lab.xml	Edgar Link	unprocessable
tsoi-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

2024 Q1 Form 10-Q Financial Statement

#000149315224021937 Filed on May 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSOI THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

2024 Q1 Form 10-Q Financial Statement

#000149315224021937 Filed on May 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi